Personal information

No personal information available

Activities

Employment (1)

Nottingham University Hospitals NHS Trust: Nottingham, GB

2020 to present | Clinical Research Fellow (Academic Clinical Neurology)
Employment
Source: Self-asserted source
Afagh Garjani

Education and qualifications (3)

University of Nottingham: Nottingham, Nottingham, GB

2024 | PhD (Academic Clinical Neurology)
Qualification
Source: Self-asserted source
Afagh Garjani

Tehran University of Medical Sciences: Tehran, IR

2018 | Board-certified Neurologist (Neurology)
Qualification
Source: Self-asserted source
Afagh Garjani

Tabriz University of Medical Sciences: Tabriz, IR

2014 | Primary Medical Qualification and MD (Faculty of Medicine)
Qualification
Source: Self-asserted source
Afagh Garjani

Funding (4)

Real-world effectiveness of COVID-19 vaccines among the entire population of MS patients taking disease-modifying therapies (DMTs) in England

2022-06 to present | Salary award
Roche Products (Nottingham, GB)
Source: Self-asserted source
Afagh Garjani

COVID-19 and MS DMTs

2021-08 to 2021-12 | Salary award
Merck (Nottingham, GB)
Source: Self-asserted source
Afagh Garjani

UK MS Register Sub-study: The impact of COVID-19 on people with MS

2020-04 to 2021-04 | Grant
MS Society (Nottingham, GB)
Source: Self-asserted source
Afagh Garjani

Spinal cord imaging in neuropathy of diabetes: longitudinal evaluation (SpINDLE)

2019-09 to 2022-08 | Grant
Nottingham University Hospitals Charity (Nottingham, GB)
Source: Self-asserted source
Afagh Garjani

Works (27)

Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis

Multiple Sclerosis Journal
2024-04 | Journal article
Contributors: Christopher GS Gilmartin; Natasha Hoyle; Afagh Garjani; Terri Dixon; Helena Jos; David Paling; Wallace Brownlee; Christopher Tench; Nikos Evangelou
Source: check_circle
Crossref

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.

Journal of neurology, neurosurgery, and psychiatry
2023-09 | Journal article
Contributors: Ruggieri S; Prosperini L; Al-Araji S; Annovazzi PO; Bisecco A; Ciccarelli O; De Stefano N; Filippi M; Fleischer V; Evangelou N et al.
Source: Self-asserted source
Afagh Garjani via Europe PubMed Central

Decentralised clinical trials in multiple sclerosis research

Multiple Sclerosis Journal
2023-03 | Journal article
Contributors: Afagh Garjani; Brandon Jun-Yu Liu; Christopher Martin Allen; Douglas David Gunzler; Stephen William Gerry; Sarah Marie Planchon; Roshan das Nair; Jeremy Chataway; Emma C Tallantyre; Daniel Ontaneda et al.
Source: check_circle
Crossref

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis

Expert Opinion on Pharmacotherapy
2023-03-04 | Journal article
Contributors: Laura Dumitrescu; Athanasios Papathanasiou; Catalina Coclitu; Afagh Garjani; Nikos Evangelou; Cris S. Constantinescu; Bogdan Ovidiu Popescu; Radu Tanasescu
Source: Self-asserted source
Afagh Garjani

Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register

Multiple Sclerosis Journal
2022-06 | Journal article
Contributors: Afagh Garjani; Rachael Hunter; Graham R Law; Rodden M Middleton; Katherine A Tuite-Dalton; Ruth Dobson; David V Ford; Stella Hughes; Owen R Pearson; David Rog et al.
Source: check_circle
Crossref

Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

Multiple Sclerosis and Related Disorders
2022-01 | Journal article
Source: Self-asserted source
Afagh Garjani

Recovery From COVID-19 in Multiple Sclerosis

Neurology Neuroimmunology & Neuroinflammation
2022-01 | Journal article
Contributors: Afagh Garjani; Rodden M. Middleton; Richard Nicholas; Nikos Evangelou
Source: check_circle
Crossref

Determinants of Recovery from the Coronavirus Disease 2019 in People with Multiple Sclerosis: The UK MS Register COVID-19 Prospective Cohort Study (4285)

Neurology
2021 | Conference abstract
Source: Self-asserted source
Afagh Garjani

COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register

Multiple Sclerosis and Related Disorders
2021-11 | Journal article
Source: Self-asserted source
Afagh Garjani

Long COVID among people with MS: A prospective and longitudinal observational study of the UK MS Register (P296)

Multiple Sclerosis Journal
2021-10 | Conference abstract
Source: Self-asserted source
Afagh Garjani
grade
Preferred source (of 3)‎

Impact of mass vaccination on SARS-CoV-2 infections among the total multiple sclerosis population receiving immunomodulatory disease-modifying therapies in England

2021-10-26 | Other
Contributors: Nikos Evangelou; Afagh Garjani; Sameer Patel; Dhiren Bharkhada; Waqar Rashid; Alasdair Coles; Graham Law
Source: check_circle
Crossref

Lymphocyte counts and the risk of COVID-19 in people with MS

Multiple Sclerosis Journal
2021-09 | Journal article
Contributors: Nikos Evangelou; Afagh Garjani
Source: check_circle
Crossref

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

Multiple Sclerosis and Related Disorders
2021-07 | Journal article
Contributors: Afagh Garjani; Rodden M Middleton; Rachael Hunter; Katherine A Tuite-Dalton; Alasdair Coles; Ruth Dobson; Martin Duddy; Stella Hughes; Owen R Pearson; David Rog et al.
Source: check_circle
Crossref

Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic study

BMJ Open
2021-06 | Journal article
Contributors: Roshan das Nair; Rachael Hunter; Afagh Garjani; Rod M Middleton; Katherine A Tuite-Dalton; Richard S Nicholas; Nikos Evangelou
Source: check_circle
Crossref

Pre-existing anxiety, depression, and neurological disability is associated with long COVID: A prospective and longitudinal cohort of the United Kingdom Multiple Sclerosis Register

2021-06-25 | Other
Contributors: Afagh Garjani; Rodden M Middleton; Richard Nicholas; Nikos Evangelou
Source: check_circle
Crossref

Spinal cord area measurement using MRI in monitoring diabetic neuropathy

http://isrctn.com/
2021-04-08 | Other
Contributors: Cris Constantinescu; Nikos Evangelou
Source: Self-asserted source
Afagh Garjani

COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies

2021-03-10 | Other
Contributors: Afagh Garjani; Rodden M Middleton; Rachael Hunter; Katherine A Tuite-Dalton; Alasdair Coles; Ruth Dobson; Martin Duddy; Stella Hughes; Owen R Pearson; David Rog et al.
Source: check_circle
Crossref

Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register

Journal of Neurology, Neurosurgery & Psychiatry
2021-01-27 | Journal article
Contributors: Nikos Evangelou; Afagh Garjani; Roshan dasNair; Rachael Hunter; Katherine A Tuite-Dalton; Elaine M Craig; William J Rodgers; Alasdair Coles; Ruth Dobson; Martin Duddy et al.
Source: check_circle
Crossref

Rebound of Multiple Sclerosis Disease Activity Following Fingolimod Cessation (P2.402)

Neurology
2017 | Conference abstract
Source: Self-asserted source
Afagh Garjani

Think beta-lactam induced encephalopathy (PO226)

Journal of Neurology, Neurosurgery & Psychiatry
2017 | Conference abstract
Source: Self-asserted source
Afagh Garjani

Association Between Platelet Count as a Noninvasive Marker and Ultrasonographic Grading in Patients With Nonalcoholic Fatty Liver Disease

Hepatitis Monthly
2015-01-18 | Journal article
Source: Self-asserted source
Afagh Garjani

Hydrocortisone Reduces Toll-Like Receptor 4 Expression on Peripheral CD14+ Monocytes in Patients Undergoing Percutanoues Coronary Intervention

Iranian Biomedical Journal
2014 | Journal article
Contributors: ; Bahram Sohrabi; Ali Akbar Movassaghpour; Simin Mashayekhi; ; ; Masoud Pezeshkian;
Source: Self-asserted source
Afagh Garjani

Association of monoctye expression of Toll-like receptor 4 and its related cytokines with coronary luminal stenosis

Advances in Bioscience and Biotechnology
2013 | Journal article
Source: Self-asserted source
Afagh Garjani

Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats

Pharmacological Reports
2012 | Journal article
Source: Self-asserted source
Afagh Garjani

Monocyte Expression of Toll-like Receptor-4 in Patients with Stable Angina Undergoing Percutanoeus Coronary Intervention

Iranian Journal of Immunology
2012 | Journal article
Source: Self-asserted source
Afagh Garjani

N-acetylaspartylglutamate (NAAG) exhibits anti-inflammatory effects on carrageenan-induced paw edema model of inflammation in rats

African Journal of Pharmacy and Pharmacology
2012-06-22 | Journal article
Part of ISSN: 1996-0816
Source: Self-asserted source
Afagh Garjani

Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat

European Journal of Pharmacology
2011 | Journal article
Source: Self-asserted source
Afagh Garjani